U.S. Prostate Cancer Testing Market is Anticipated to Reach $1,901.6 million in 2030
The U.S. prostate cancer testing market is anticipated to reach $1,901.6 million in 2030 from $544.1 million in 2021, with a CAGR of 14.7%, during the forecast period 2022-2030.
